Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clexane Dosing in Postpartum Women for VTE Prevention
NCT02856295Phase 4Completed
- Sponsor
- Emek Medical Center
- Start
- Nov 2021
- Primary completion
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in venous thromboembolism (VTE), sponsored by Emek Medical Center. Started Nov 2021; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02856295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02856295.